Schnieders Capital Management LLC Has $529,000 Stake in Intuitive Surgical, Inc. $ISRG

Schnieders Capital Management LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 973 shares of the medical equipment provider’s stock after buying an additional 268 shares during the quarter. Schnieders Capital Management LLC’s holdings in Intuitive Surgical were worth $529,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Chilton Capital Management LLC grew its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. bought a new position in shares of Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $30,000. TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at $30,000. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $580.29.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $446.13 on Monday. The firm has a market cap of $159.93 billion, a PE ratio of 62.22, a P/E/G ratio of 4.69 and a beta of 1.61. The business’s 50 day simple moving average is $454.97 and its 200 day simple moving average is $495.76. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the firm posted $1.78 EPS. The business’s revenue was up 21.4% on a year-over-year basis. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.